Why the study?
Does inhibiting glycolysis and hexosamine biosynthesis reduce inflammatory protein expression and monocyte recruitment in human aortic valve cells?
Does inhibiting glycolysis and hexosamine biosynthesis reduce inflammatory protein expression and monocyte recruitment in human aortic valve cells?
Glycolysis and hexosamine biosynthesis are crucial for inflammatory protein maturation and monocyte recruitment in human aortic valve cells, highlighting potential metabolic targets for early-stage calcific aortic valve disease.
No takes yet. Share an insight, caveat, or question.
Should not change valve disease care; leaves open whether glycolytic inhibition will prove therapeutic in patients.
Sánchez‐Bayuela et al. (2026) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: